| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918458 | Radiotherapy and Oncology | 2014 | 6 Pages |
Abstract
This phase I study combining low-dose ultra-fractionated RT as a sensitizer to full dose G plus E was well tolerated with encouraging efficacy. This represents a novel strategy worthy of further investigation in advanced pancreatic cancer patients.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Andre Konski, Joshua E. Meyer, Michael Joiner, Michael J. Hall, Philip Philip, Anthony Shields, Erin McSpadden, Minsig Choi, Beth Adaire, Gail Duncan, Neal J. Meropol, Terrence P. Cescon, Steven J. Cohen,